Knockdown of the BH3-family protein Mcl-1 using shRNA sensitised the melanoma cells to U0126-induced apoptosis, showing that overexpression of these key anti-apoptotic proteins in melanoma is a critical barrier to an effective BRAF/MEK inhibitor therapy. The gene discussed is MAP2K7; the disease is melanoma.